Alivus Life Sciences Ltd

NSE: ALIVUS · BSE: 543322 · Pharmaceuticals & Biotechnology · 23 announcements

Share price

₹1,384.70

Market cap

₹17,000 Cr

Revenue (annual)

₹2,552 Cr

Net profit (annual)

₹564.5 Cr

P/E (TTM)

28.2×Sector 47.4×

Promoter holding

74.87%+0.00% QoQ

FII holding

5.54%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.